In Russia launched the first application with a section to support patients on therapy Sejaro and Semavik

The first application that combines information about GLP-1-based weight loss drugs with practical tools for long-term body weight control has appeared on the Russian market.

GEROPHARM said that for patients receiving Sejaro, Semavik and Semavik Next, the Stroynee app provides separate educational programs and features to track dosages and schedules of injections, nutrition, physical activity and emotional state. This is reported by newstula.ru. Users can also refer to materials prepared by doctors and experts, and engage in video training of Olympic champion Irina Slutskaya.

To support motivation helps game mechanics – “hero card” with daily tasks and rewards, which should help patients not to lose involvement and consistently move towards the goal. According to experts, this combination of digital support and therapy contributes not only to weight loss, but also to the formation of stable habits with less psychological stress.

The effectiveness of mobile solutions in weight management is confirmed by the analysis of an international team of scientists. The study showed that the use of mobile applications leads to a statistically significant and sustained decrease in body weight and waist circumference, whereas conventional web resources do not provide such a result. The key factor is the mobile format, which gives constant access to monitoring and support tools.

GEROPHARM CEO Peter Rodionov noted that the goal of digital tools is to reduce psychological barriers in therapy, including fear of injections and lack of understandable information, as well as to give patients the opportunity to get a controlled and measurable result.